Great post Smitter.This is going to my favorites.I believe there is a lot of wisdom in what you said there.I too have been down a similar path although I cant admit to being as far along as you which is fine as long as I know that the good posters are "not" like the pumpers but offer true valuable info with little regard in trying and white wash a company.GEQU fortunately dosen't need that and like you said I too think there is no reason fundamentally we should npt return to past a dime and more.No it doesnt happen over week bit as they flow together we will see a price jump due to the toxic gone and peeps looking in and seeing that this company is no run of the mill stock.May you all have a great weekend and anticipate the good things coming our way!;)
Smitter, in all honesty - you are the reason that I'm still here. Thank you for an excellent post. There's not too many people you can trust in OTC however I think you are one to be trusted. I've learned a ton from you too about dilution through GEQU which I'm finding is the first thing you should learn before jumping in. I'm patient and will be with ya'll for a while! I hope you have a great weekend. (((CHEERS)))
What an excellent post/trading bio! For all who read it- he is referring to king koopa not his minion Koopa Troopa! In real life we are identical twins but in trading world I am his minion. Haha! I am learning my lesson on dilution from LIB*. Thankfully I was smart enough to follow king koopa to GEQU and more than make up for 5 grand I donated to KBM via LIB*. GEQU is a real winner and I look forward to what is to come!
However I do not agree with this statement in entirety:
Toxic debt is but one piece of the puzzle to dissect and comprehend fully. The question beyond that is why did the company have to resort to toxic financing if they are so great in the first place? In all my years I have only seen two companies escape this cycle, and they were bios with legitimate pipeline projects that had fallen on hard times. I witnessed these bios escape the toxic financing mill, and that was because their phase 2 and 3 results drew attention and garnered traditional financing on reasonable terms, with institutional buying on set prices in private placements. Which of course was dilution, but on understandable terms.
GEQU needs to show actual cash on the books in the next quarter. Equity in other private ventures and cash that instantly disappears does not garner real market investment. I applaud the company's SEC filings for not being OTC crap that cannot be pieced together logically. But they still need to show a cash position and not just deferring salary accrued converted in commons down the road.
My suggestion to the principals of this stock would be to halt SG&A expenses until the company cash position can comfortably pay that out of actual revenue coming in. That would go a long way in lending legitimacy and not another clever fleecing of the public, which is always a possibility in the stock world, on any exchange, even the NYSE.